Apotheek Lierseweg

Active

Private limited companyfounded 2011active for 15 yearsLierseweg(HRT) 177, 2200 Herentals, BelgiumKBO/BCE: BE 0837.740.696

From the official registers: KBO 14 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Apotheek Lierseweg has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €537,085 and a net result of €163,929. Equity has been growing by about 12% per year since 2019. Its solvency ranks better than 45% of 12,757 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow Report Compare

Apotheek LiersewegActiveChecked score 93/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 04-07-2011 Normal situation
Legal form: Private limited company
Registered office: Lierseweg(HRT) 177, 2200 Herentals
Activity: Retail sale of pharmaceutical products NACE 47730
Establishment unit: 2.201.459.144 2200 Herentals, since 11-07-2011
Financial year end: 31 December
Peppol: Reachable since 01-12-2025

Company details

Board and ownership

Board

K & TDirector · permanent representative DE GROOF Karolien Marie Jan

Shareholders

K & T100%annual accounts 2025

Board & ownership

Financial position

93 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: 0.1%

Annual accounts 2025

Gross margin: €374,818; ▲ 0.1%
Turnover: ≈ €1.4m; estimated
Profit: €163,929; ▲ 28.6%
Equity: €537,085; ▲ 43.9%
Total assets: €1.7m; ▲ 10.2%
Staff: 2.5 FTE; ▲ 13.6%

2025 accounts filed 38 days before the deadline

Filed on 23-06-2026at the National Bank

Financials

Score breakdownlowers riskFigures for financial year 2025 (filed on 23-06-2026)Founded in 2011Liquidity: current ratio 2.17, cash €307,534Size: 2.5 FTE, total assets €1.7mShow the evidence

Checked score

Score 2025

93 / 100

Excellent

Probability in this band: under 0.55%

Financially stronger than 64% of micro companies in retail trade (NACE 47)

Every signal that counts is listed under Signals.

Financial strength · tick: 2025

Strong

Solvency 57+7

equity 32.0% of total assets

Liquidity 66+5

short-term debt 21.4% · cash 18.3%

Profitability 81+2

return on assets 9.8%

Bankruptcy probability within 12 months

0.1% Very low

0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)

Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.2%● unchanged vs 06-2025 08-2025: 0.2%● unchanged vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025highest value 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.2%● unchanged vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.1%▼ -0.1 percentage points vs 09-2026lowest value

Credit of up to €45,000 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 2.17, above the usual 1.5. Short-term debt is 21.4% and cash 18.3% of total assets. However, 68% of the assets are financed with debt and provisions.

Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 48% of them on solvency, 72% on liquidity and 73% on profitability.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskneutral

Figures for financial year 2025 (filed on 23-06-2026)

NBB · annual accounts

Founded in 2011

Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.

KBO

Liquidity: current ratio 2.17, cash €307,534

NBB · annual accounts

Size: 2.5 FTE, total assets €1.7m

Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.

NBB · annual accounts

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-06-2026, 38 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

38 days early

2025

32 days early

2024

20 days early

2023

35 days early

2022

3 days late

2021

2 days late

2020

30 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 21 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (1)

No strike-offs in the KBO publications

That holds for every publication since 2021.

KBO publications

Key points

Caution: Board changedlatest change 17-11-2025 · 1 in office 1 joined · 1 left View
Positive: Higher net result than 85% of companies in retail tradesector median €27,641 · 12,747 companies €163,929 View
Positive: Filed on time since financial year 2023accounts within the deadline every year 4 years View

Documents

Key facts about Apotheek Lierseweg

What is the company number of Apotheek Lierseweg?: The company number of Apotheek Lierseweg is 0837.740.696. The VAT number is the same number with BE in front: BE 0837.740.696.
Where is Apotheek Lierseweg based?: The registered office is at Lierseweg(HRT) 177, 2200 Herentals.Company details
What does Apotheek Lierseweg do?: According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Lierseweg?: The legal form of Apotheek Lierseweg is Private limited company (BV).
When was Apotheek Lierseweg founded?: Apotheek Lierseweg was founded on 04-07-2011.
Is Apotheek Lierseweg still active?: Yes, Apotheek Lierseweg is an active enterprise in the KBO register.
How many employees does Apotheek Lierseweg have?: Apotheek Lierseweg had an average of 2.5 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Apotheek Lierseweg?: The turnover in financial year 2025 is ≈ €1.4m. This figure is estimated from the gross margin of €374,818 and 47 comparable companies (NACE 477). It probably lies between €1.1m and €2.2m.
Is Apotheek Lierseweg profitable?: In financial year 2025, Apotheek Lierseweg made a profit of €163,929.
Where can I find the annual accounts of Apotheek Lierseweg?: Apotheek Lierseweg filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank

Companies linked to Apotheek Lierseweg

Parent and group

K & T100%

Comparable companies

These companies have the same main activity as Apotheek Lierseweg: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.5m and €1.8m, founded between 2007 and 2014.

Company	Total assets	Gross margin
Apotheek Lierseweg Herentals	€1.7m	€0.4m
Pharmacie Gosselin-Obourg Mons	€1.8m	€0.4m
LEFEVRE PHARMA Fleurus	€1.5m	€0.3m
PHARMA-LOUVE Seneffe	€1.5m	€0.4m
APOTHEEK BRONDEL Eeklo	€1.7m	€0.4m
PHARMACIE MARCOURT Chaudfontaine	€1.7m	€0.4m
Apotheek Eva Lachaert Merelbeke-Melle	€1.5m	€0.4m